XTalks

JANUARY 5, 2024

Among its services, Lilly said LillyDirect provides disease management resources that include access to independent healthcare providers, personalized support and direct delivery of select Lilly medications to homes via third-party pharmacy dispensing services.

Drugs 59

Drugs Pharmacy Cosmetics Medicine 59

pharmaphorum

JANUARY 6, 2023

On 14th November 2022, Eli Lilly apparently wrote on its Twitter account, “We are excited to announce insulin is free now.” As the Russian invasion has continued, some of these trials were able to resume , but the pace of research and development had suffered. Industry frustrations. New drug launches were delayed.

Manufacturing 105

Manufacturing Sales Insulin Drugs 105

Drug Channels

DECEMBER 16, 2020

I expect manufacturers to escalate their challenges to the contract pharmacy elements of the program. Meanwhile, covered entities will be battling manufacturers, state Medicaid programs, their contract pharmacy partners, and perhaps even HRSA itself. Click here to see the original post and comments from September 2020.

Pharmacy 40

Pharmacy Insulin Manufacturing Drugs 40

pharmaphorum

APRIL 1, 2022

Semglee (insulin glargine-yfgn) is the first biosimilar available at the retail pharmacy counter, and it obtained interchangeable status. And, manufacturers will likely pay close attention to the impact of Semglee’s interchangeable designation on the adoption of biosimilars in the retail pharmacy space.

Marketing 59

Marketing Pharmacy FDA Approval Manufacturing 59

XTalks

FEBRUARY 14, 2024

Allocation of Profits, PBMs Under Fire The CEOs defended high prescription drug prices saying that a big chunk of pharma profits go towards funding the research and development of new medicines. Explain how you justify that division of dividends and stock buybacks versus research and development.

Drugs 52

Drugs Insulin Pharmacy Development 52

pharmaphorum

JULY 13, 2022

The lack of measurability in neurological diseases plagues pharma every step of the way when it comes to drug development. One reason for that is that they, along with things like the gait test, can only be administered in a single moment, and neurological diseases can develop inconsistently, causing the patient to have up and down days.

Trials 98

Trials Clinical Trials Clinical Trials Pharma Companies 98

Pharmaceutical Technology

MARCH 8, 2023

Eli Lilly has announced that it will reduce the price of its most commonly used insulin, Humalog, in the US, by 70% and cap the out-of-pocket cost for those on commercial insurance at $35. This is the second time Lilly has significantly reduced the cost of its insulin, as in 2019 the company reduced the list price of Humalog by 50%.

Insulin 264

Insulin Branding Marketing Pharmacy 264

pharmaphorum

APRIL 13, 2022

The treatment has been around for over a century but insulin has still become the centre of the ongoing discussion over pricing of pharmaceutical products. Ben Hargreaves looks at why insulin’s price is so controversial and whether this could be set to change. Insulin rationing. In the US, approximately 37.3

Insulin 130

Insulin Drugs Production Hormones 130

XTalks

JUNE 12, 2023

These powerhouse organizations have not only distinguished themselves through their cutting-edge devices and technologies but also via their robust research and development (R&D) capabilities, unwavering commitment to quality and extensive global reach. The company reported an investment of $2.7

FDA Approval 98

FDA Approval Production Sales In-Vitro 98

pharmaphorum

JANUARY 13, 2023

The ‘big three’ insulin producers Novo Nordisk, Eli Lilly, and Sanofi are being sued by the state of California for allegedly working together to set artificially inflated prices for their products. The suit follows legal action over insulin pricing taken by other states, including Arkansas , Kansas, Mississippi, and Minnesota.

Insulin 105

Insulin Manufacturing Production Drugs 105

XTalks

FEBRUARY 8, 2021

As a subset of biosimilars, interchangeable biological products can be substituted for the reference product at the pharmacy level, without the input of the prescribing physician. Biosimilars developers may also be required to conduct PK/PD studies and assess the immunogenicity of their product prior to approval.

Production 78

Production Insulin Branding Generic Drugs 78

XTalks

FEBRUARY 8, 2024

Ozempic (Semaglutide) Ozempic sales in 2022: $8.713 billion Company/Developer: Novo Nordisk Date of first FDA approval: December 5, 2017 Indications Ozempic is FDA-approved for: Type 2 diabetes Price of Ozempic: $1,029 for 1.5 Trulicity (Dulaglutide) Trulicity sales in 2022: $7.439 billion Company/Developer: Eli Lilly & Co.

Sales 52

Sales Insulin FDA Approval Drugs 52

STAT News

MARCH 10, 2023

Enjoy, and see you soon … By law, Medicare will have to take a medication’s efficacy and its research and development costs into account when it starts to negotiate drug prices — but recent research shows pharma companies ignore those factors when they pick prices for their products , STAT explains. But be safe.

Insulin 96

Insulin Pharmacy Pharma Companies Drugs 96

STAT News

NOVEMBER 18, 2022

The document says that public funding for the development of vaccines and treatments should be more transparent, and include provisions to ensure that any resulting products are distributed evenly around the world. The first therapy that delays the onset of type 1 diabetes received approval from the U.S.

Insulin 98

Insulin FDA Approval Production Pharmacy 98

XTalks

FEBRUARY 2, 2023

The higher discounted price will likely not appeal to pharmacy benefit managers (PBMs) that recommend which drugs most insurance providers should cover, according to Reuters. Despite being more expensive, the branded version ended up being favored by PBMs and insurers over the cheaper unbranded one because of the steep rebates for the former.

Marketing 52

Marketing FDA Approval Branding Drugs 52

STAT News

DECEMBER 5, 2022

… Johnson & Johnson said it does not intend to make an offer for Horizon Therapeutics, days after the developer of medicines for rare autoimmune and inflammatory diseases revealed it was in talks with the company , Bloomberg News writes. We hope you have a smashing day and, of course, encourage you to keep in touch.

Insulin 52

Insulin Manufacturing Medicine Drugs 52

Pharmacy Checkers

JULY 2, 2019

One of the Sustainable Development Goals, 3.8 , created under UN auspices is: “Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all.” My comment is below. In support of SDG 3.8,

Medicine 49

Medicine Pharmacy Regulation Development 49

pharmaphorum

JUNE 10, 2021

It can be reasonably argued that the upfront research and development of vaccine technologies leveraging mRNA – which can be widely applied against a number of viruses – will be the solutions that end our current pandemic and will effectively position society to be ready for the next. Is the Middleman at Fault?

Manufacturing 105

Manufacturing Drugs Pharma Companies Pharmacy 105

XTalks

JANUARY 24, 2024

Americans consistently pay more for prescription drugs than people in other developed countries. This disparity can be attributed to various factors, including the lack of government regulation on drug prices and the complex web of negotiations between drug manufacturers, insurers and pharmacy benefit managers.

Drugs 64

Drugs Medicine Insulin Packaging 64

pharmaphorum

SEPTEMBER 1, 2020

The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. The national rivalries and conflicts that characterised this period also had their impact on the developing industry. pharmaphorum looks at its evolution over the centuries.

Medicine 145

Medicine Insulin Drugs Pharmacy 145

pharmaphorum

NOVEMBER 4, 2021

Other elements of the plans include tax penalties if pharma companies hike their prices faster than inflation, setting a cap of $35 per month out-of-pocket for insulin, and making sure that Medicare Part D patients don’t pay more than $2,000 per year for medications bought at the pharmacy.

Drugs 52

Drugs Insulin Medicine Marketing 52

Pharmacy Checkers

MARCH 11, 2020

Founded in 2002, and launching its website in 2003, PharmacyChecker provides consumers with online pharmacy verification and comparative drug price information to help them make the best decisions for themselves and their families on how to afford prescription drugs. counterparts.

Pharmacy 41

Pharmacy Drugs FDA Approval Licensing 41